Cargando…
CD44v6: A metastasis-associated biomarker in patients with gastric cancer?: A comprehensive meta-analysis with heterogeneity analysis
BACKGROUND: The diagnostic and prognostic value of CD44v6 in patients with gastric cancer remains unclear. Therefore, a quantitative meta-analysis was conducted to determine the clinical value of CD44v6 in patients with gastric cancer. METHODS: Sixteen studies with 2177 patients were included. Poole...
Autores principales: | Lu, Li, Huang, Fei, Zhao, Zhicheng, Li, Chuan, Liu, Tong, Li, Weidong, Fu, Weihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5268045/ https://www.ncbi.nlm.nih.gov/pubmed/27977599 http://dx.doi.org/10.1097/MD.0000000000005603 |
Ejemplares similares
-
Prognostic value of CD44v9 expression in human cancers: A systematic review and meta-analysis
por: Zeng, Li, et al.
Publicado: (2020) -
Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer: A comprehensive meta-analysis with 4729 patients involved
por: Lu, Li, et al.
Publicado: (2016) -
Comprehensive analysis of pan-cancer reveals the potential of SLC16A1 as a prognostic and immunological biomarker
por: Chen, Lingyun, et al.
Publicado: (2023) -
The diagnostic value of interleukin 6 as a biomarker for gastric cancer: A meta-analysis and systematic review
por: Wang, Xiaozi, et al.
Publicado: (2021) -
Diagnostic Value of Wilms Tumor 1 and CD44 in Langerhans Cell Sarcoma: Case Series of 4 Patients
por: Wang, Chang-song, et al.
Publicado: (2015)